Outset Medical, Inc. (OM)
NASDAQ:OM
Want to see OM full AI Analyst Report?
OM Stock Chart & Stats
$4.35
-$0.10(-9.09%)
At close: 4:00 PM EST
$4.35
-$0.10(-9.09%)
Day’s Range― - ―
52-Week Range$3.00 - $21.98
Previous CloseN/A
Volume1.92M
Average Volume (3M)152.80K
Market Cap
$68.88M
Enterprise Value$55.31M
Total Cash (Recent Filing)$156.71M
Total Debt (Recent Filing)$4.68M
Price to Earnings (P/E)―
Beta1.86
Next Earnings
Aug 05, 2026EPS Estimate
-0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.16
Shares Outstanding18,537,241
10 Day Avg. Volume224,958
30 Day Avg. Volume152,803
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.44
Price to Sales (P/S)0.47
P/FCF Ratio-1.20
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue0.47
Enterprise Value/Gross Profit1.16
Enterprise Value/Ebitda-0.88
Forecast
1Y Price Target
$7.67Price Target Upside76.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-2.86
Revenue Forecast (FY)$126.77M
Bulls Say, Bears Say
Bulls Say
Clinical Outcomes And Infection ReductionMonitoring treatment metrics with the Tablo system revealed links between ultrafiltration and bloodstream infections, enabling protocol changes that reduced central line use and lowered infection risk.
Commercial Pipeline And Sales MomentumA strengthened console pipeline, clearer forecasting, and sequential growth in console and product sales signal improving demand and better visibility into future orders.
Revenue Mix And MarginsA higher consumables mix combined with lower per-treatment supply costs supports improving gross margins while recurring consumables and service revenue provide a steadier income base.
Bears Say
Operational Staffing RiskHigh nurse turnover and elevated staffing demands forced reductions in non-critical care hours, increasing operational strain and potentially slowing hospital transitions to in-house dialysis services.
Profitability And Cash UseAdjusted loss per share was worse than analysts expected due to higher general and administrative expenses and continued cash use, putting pressure on near-term profitability and balance sheet flexibility.
Outset Medical News
OM FAQ
What was Outset Medical, Inc.’s price range in the past 12 months?
Outset Medical, Inc. lowest stock price was $3.00 and its highest was $21.98 in the past 12 months.
What is Outset Medical, Inc.’s market cap?
Outset Medical, Inc.’s market cap is $68.88M.
When is Outset Medical, Inc.’s upcoming earnings report date?
Outset Medical, Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 76 days.
How were Outset Medical, Inc.’s earnings last quarter?
Outset Medical, Inc. released its earnings results on May 07, 2026. The company reported -$0.83 earnings per share for the quarter, missing the consensus estimate of -$0.79 by -$0.04.
Is Outset Medical, Inc. overvalued?
According to Wall Street analysts Outset Medical, Inc.’s price is currently Undervalued.
Does Outset Medical, Inc. pay dividends?
Outset Medical, Inc. does not currently pay dividends.
What is Outset Medical, Inc.’s EPS estimate?
Outset Medical, Inc.’s EPS estimate is -0.72.
How many shares outstanding does Outset Medical, Inc. have?
Outset Medical, Inc. has 18,537,241 shares outstanding.
What happened to Outset Medical, Inc.’s price movement after its last earnings report?
Outset Medical, Inc. reported an EPS of -$0.83 in its last earnings report, missing expectations of -$0.79. Following the earnings report the stock price went down -21.047%.
Which hedge fund is a major shareholder of Outset Medical, Inc.?
Currently, no hedge funds are holding shares in OM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Outset Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.67 (76.25% Upside)
$7.67 (76.25% Upside)
Blogger Sentiment
Bullish
OM Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 36.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.4%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.28%
12-Months-Change
Fundamentals
Return on Equity
-55.88%
Trailing 12-Months
Asset Growth
-17.18%
Trailing 12-Months
Company Description
Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
OM Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a largely positive operational and financial trajectory: substantial gross margin expansion (620 bps), a 32% improvement in non-GAAP net loss, strong cash balance ($161M) with lower-than-expected cash burn, and a strategic next-generation product and experienced commercial hire poised to drive future demand. Offsetting these positives were a 6% year-over-year revenue decline in Q1 driven by lumpiness in capital orders (product revenue down 13%), modestly higher operating expenses, and reliance on the timing and success of the next-gen Tableau launch to deliver back-half revenue. On balance, the positive margin, cash, and operational execution updates outweigh the timing-related revenue headwinds.View all OM earnings summariesOM Revenue Breakdown
47.04% Consoles
32.37% Consumables
20.59% Service and other revenue
OM Stock 12 Month Forecast
Average Price Target
$7.67
▲(76.25% Upside)
Technical Analysis
Ownership Overview
17.83% Insiders
22.15% Mutual Funds
24.03% Other Institutional Investors
26.94% Public Companies and
Individual Investors